Insider · CIK 0001219844

PATRICK GREGORY S

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001219844

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-11-09	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+5,000 sh	$12.98	+$64.9K	49,463
2020-11-09	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−5,000 sh	$25.00	−$125K	44,463
2020-11-09	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	10,000
2020-11-05	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+5,000 sh	$12.98	+$64.9K	49,463
2020-11-05	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−5,000 sh	$23.00	−$115K	44,463
2020-11-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	15,000
2020-10-15	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$12.98	+$195K	59,463
2020-10-15	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−15K sh	$20.03	−$301K	44,463
2020-10-15	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	20,000
2020-08-27	SUPNSUPERNUS PHARMACEUTICALS, INC.G Gift	Sr. VP Chief Financial Officer	GGift	−1,120 sh	—	—	44,463
2020-08-25	SUPNSUPERNUS PHARMACEUTICALS, INC.G Gift	Sr. VP Chief Financial Officer	GGift	−1,000 sh	—	—	45,583
2020-05-20	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$12.98	+$195K	61,057
2020-05-20	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−15K sh	$25.03	−$375K	46,057
2020-05-20	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	35,000
2020-05-08	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$9.13	+$137K	61,057
2020-05-08	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−15K sh	$23.14	−$347K	46,057
2020-05-08	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	0
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	−50K sh	—	—	50,000
2019-07-31	SUPNSUPERNUS PHARMACEUTICALS, INC.G Gift	Sr. VP Chief Financial Officer	GGift	−2,590 sh	—	—	45,682
2019-02-27	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+20K sh	$9.13	+$183K	67,896
2019-02-27	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−20K sh	$41.53	−$831K	47,896
2019-02-27	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	15,000
2019-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	+40K sh	—	—	40,000
2018-12-03	SUPNSUPERNUS PHARMACEUTICALS, INC.G Gift	Sr. VP Chief Financial Officer	GGift	−8,600 sh	—	—	47,896
2018-07-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+20K sh	$9.24	+$185K	75,975
2018-07-02	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$9.13	+$137K	90,975
2018-07-02	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−35K sh	$56.63	−$1.98M	55,975
2018-07-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	0
2018-07-02	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	35,000
2018-02-14	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	+30K sh	—	—	30,000
2017-09-08	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+23.5K sh	$7.90	+$185K	39,197
2017-09-08	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−23.5K sh	$48.89	−$1.15M	15,716
2017-09-08	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$5.88	+$88.2K	30,716
2017-09-08	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−23.5K sh	—	—	20,000
2017-09-08	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	25,000
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+26.5K sh	$7.90	+$210K	27,235
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−25K sh	$46.36	−$1.16M	2,235
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−1,519 sh	$48.00	−$72.9K	716
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+15K sh	$5.88	+$88.2K	15,716
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−26.5K sh	—	—	43,481
2017-09-07	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	40,000
2017-04-24	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	+50K sh	$5.88	+$294K	54,221
2017-04-24	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−54K sh	$32.37	−$1.75M	221
2017-04-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP Chief Financial Officer	MExercise/Conversion	−50K sh	—	—	55,000
2017-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	+50K sh	—	—	50,000
2016-09-16	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−2,000 sh	$25.00	−$50K	3,616
2016-07-14	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−3,395 sh	$22.00	−$74.7K	5,616
2016-03-01	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	+50K sh	—	—	50,000
2015-07-16	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP Chief Financial Officer	SSale	−6,217 sh	$20.00	−$124K	7,344
2015-03-03	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP Chief Financial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Nov 104
PATRICK GREGORY S0001104659-20-123596
SEC(opens sec.gov)
Nov 64
PATRICK GREGORY S0001104659-20-122611
SEC(opens sec.gov)
Oct 154
PATRICK GREGORY S0001104659-20-115378
SEC(opens sec.gov)
Aug 284
PATRICK GREGORY S0001104659-20-100179
SEC(opens sec.gov)
May 204
PATRICK GREGORY S0001104659-20-064386
SEC(opens sec.gov)
May 114
PATRICK GREGORY S0001104659-20-059729
SEC(opens sec.gov)
Feb 254
PATRICK GREGORY S0001104659-20-024847
SEC(opens sec.gov)
Aug 14
PATRICK GREGORY S0001104659-19-043393
SEC(opens sec.gov)
Feb 284
PATRICK GREGORY S0001104659-19-011559
SEC(opens sec.gov)

Companies

SUPERNUS PHARMACEUTICALS, INC.Sr. VP Chief Financial OfficerSUPN

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850